^
Association details:
Evidence:
Evidence Level:
Sensitive: D – Preclinical
New
Title:

Disruption of NSD1 in Head and Neck Cancer Promotes Favorable Chemotherapeutic Responses Linked to Hypomethylation

Excerpt:
In each case, cell lines with NSD1 disruption were more sensitive to cisplatin than the parental wild-type cell lines...To mimic the loss of NSD1 pharmacologically, we performed a separate experiment in which parental cells were pre-treated with the HMT inhibitor UNC0379, which also rendered the HNSCC cell lines more sensitive to cisplatin with a growth response that was nearly identical to direct NSD1 disruption...In each case, cell lines with NSD1 disruption were more sensitive to cisplatin than the parental wild-type cell lines...To mimic the loss of NSD1 pharmacologically, we performed a separate experiment in which parental cells were pre-treated with the HMT inhibitor UNC0379, which also rendered the HNSCC cell lines more sensitive to cisplatin with a growth response that was nearly identical to direct NSD1 disruption...
DOI:
10.1158/1535-7163.MCT-17-0937